Cited by 181Bone health and osteoporosis researchBone Metabolism and DiseasesPituitary Gland Disorders and Treatments

Pituitary Diseases and Bone

Open access
Mazziotti, Gherardo, Frara, Stefano, Giustina, Andrea·2018·Endocrine Reviews

Abstract

Neuroendocrinology of bone is a new area of research based on the evidence that pituitary hormones may directly modulate bone remodeling and metabolism. Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia. As in other forms of secondary osteoporosis, pituitary diseases generally affect bone quality more than bone quantity, and fractures may occur even in the presence of normal or low-normal bone mineral density as measured by dual-energy X-ray absorptiometry, making difficult the prediction of fractures in these clinical settings. Treatment of pituitary hormone excess and deficiency generally improves skeletal health, although some patients remain at high risk of fractures, and treatment with bone-active drugs may become mandatory. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary diseases.

AI snapshot

Written from the paper’s full text.

TL;DR

Pituitary hormone excess or deficiency commonly causes skeletal fragility, often with fractures despite normal or low-normal bone mineral density by DXA. This narrative review synthesizes mechanisms and clinical evidence across acromegaly, prolactinoma, Cushing disease, TSH-oma, and hypopituitarism, emphasizing morphometric vertebral assessment and the limits of BMD for fracture prediction.

Key findings

  • Vertebral fractures are a frequent complication of pituitary diseases; DXA does not reliably predict fracture risk, and morphometric vertebral assessment is currently the mainstay for skeletal evaluation.
  • In acromegaly, the overall median prevalence of vertebral fractures is ~40%, with fracture risk threefold to eightfold higher than controls; a prospective study found incident vertebral fractures in 42% of patients over 3 years, related to active disease and duration.
  • In prolactinoma, radiological vertebral fractures occurred in 32.6% of women (25/78) and 37.5% of men; 80% of male patients had osteopenia or osteoporosis at the lumbar spine, whereas only 30% had low femoral neck BMD.
  • In Cushing disease, DXA osteoporosis prevalence is 28% to 50%, fracture prevalence 15% to 50%, and morphometric vertebral fracture prevalence 78%; in growth hormone deficiency, fracture risk is twofold to fivefold higher, more than 60% of adults had vertebral fractures in one study, and after 6 years untreated GHD had a sevenfold higher risk of vertebral fractures than treated GHD.

Methods

  • Narrative review of physiological, pathophysiological, and clinical literature on bone involvement in pituitary diseases, including hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia.
  • Synthesizes experimental, observational, cross-sectional, prospective, and meta-analytic evidence; includes tables of studies evaluating fragility fractures and bone structure in acromegaly, prolactinoma, Cushing disease, and hypopituitarism.
  • No new primary patient data or systematic review methodology are reported.

Limitations

  • Stated: no specific guidelines have been published on monitoring skeletal health in pituitary diseases, so monitoring cannot be evidence based; no randomized controlled trials evaluate rhGH effects on fracture risk; no studies have tested antiosteoporotic drugs in acromegaly; clinical relevance of IGFBP skeletal effects and FSH effects in humans remains unclear.
  • Evident from the text: as a narrative review, it does not use a systematic search or formal meta-analysis, and many cited fracture studies are cross-sectional or retrospective, with heterogeneous designs and endpoints.
  • Evident from the text: DXA limitations are repeatedly noted, including inability to capture bone quality, microstructure, and compartment-specific changes, which affects fracture prediction in these populations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/er.2018-00005

Cites

659 of 659 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

2 of 135 cited sources checked · 2 supported · 0 flagged

  • Premisecitation

    In igfbp-4-null female mice, cortical area fraction and cortical thickness at the femur midshaft are significantly reduced.

    “Significant reductions were also observed in cortical area fraction and cortical thickness at the femur midshaft.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [155] Maridas, 2017, IGFBP-4 regulates adult skeletal growth in a sex-specific manner, J Endocrinol source
  • Premisecitation

    In this study baseline TBS was normal.

    “However, in this study baseline TBS was normal.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [449] Allo Miguel, 2016, Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center, Ther Adv Endocrinol Metab source
  • Study design and conductcitation

    Questionnaires and databases cannot correctly identify vertebral fractures.

    “likely reflecting the impossibility of questionnaires and databases to correctly identify VFs ().”
    Quote in the paperSubstantial claim
  • Interpretationreasoning

    Increased bone formation seen in vivo is likely due to coupling of bone formation to bone resorption, which is absent in in vitro conditions.

    “Increased bone formation seen in vivo was likely due to the coupling of bone formation to bone resorption, which was absent in in vitro conditions.”
    Quote in the paperSubstantial claim
  • Premisecitation

    Despite the stimulating effects of GH and IGF-I on renal activation of vitamin D, hypovitaminosis D has been consistently reported in patients with acromegaly.

    “Despite the stimulating effects of GH and IGF-I on renal activation of vitamin D (), hypovitaminosis D has been consistently reported in patients with acromegaly (, ), and there is also evidence suggesting lower peripheral bioavailability of vitamin D in this clinical setting as an effect of an increase in vitamin D binding protein (, ).”
    Quote in the paperNot a substantial claim
  • May combine two claims. 76
  • Classified as probably not a substantial claim. 11
  • The quote only partly states this claim. 2
  • May combine two claims.

    Findingcitation

    In a meta-analysis of 13 studies, acromegaly did not induce a significant change in BMD at the lumbar spine, whereas BMD was increased at the femoral neck and total hip.

    “In a meta-analysis performed in  studies (, , , , -), acromegaly did not induce a significant change in BMD at the lumbar spine, whereas BMD was increased at the femoral neck and total hip ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Fractures may occur even in the presence of normal or low-normal bone mineral density as measured by dual-energy X-ray absorptiometry, making prediction of fractures difficult.

    “fractures may occur even in the presence of normal or lownormal bone mineral density as measured by dual-energy X-ray absorptiometry, making difficult the prediction of fractures in these clinical settings.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [1] Mazziotti, 2015, Pituitary diseases and bone, Endocrinol Metab Clin North Am source
  • May combine two claims.

    Findingcitation

    Beneficial effects of alendronate on BMD were accompanied by a decrease in VF incidence, although the study was not powered for this endpoint.

    “The beneficial effects of alendronate on BMD were accompanied by a decrease in VF incidence, although the study was not powered for this endpoint.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [612] Biermasz, 2004, Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study, Clin Endocrinol (Oxf) source
  • May combine two claims.

    Findingcitation

    In GHD patients treated with rhGH, pamidronate attenuated the increase in bone turnover and prevented the decline in BMD in the first months.

    “The bisphosphonate, administered up-front in six GHD patients treated with rhGH, attenuated the increase in bone turnover and prevented the decline in BMD eventually observed in the first months of GH substitutution.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [609] Valk, 1995, Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass, Clin Endocrinol (Oxf) source
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given

    Reduced BMD is not so frequent in patients with acromegaly.

    “particularly in the presence of reduced BMD, a finding that is not so frequent in patients with acromegaly.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductcitation

    DXA measurement of BMD in acromegaly could be influenced by the bone enlargement caused by GH excess, although the effects on bone mineral content seem to overcome those on bone area.

    “Moreover, DXA measurement of BMD in acromegaly could be influenced by the bone enlargement caused by GH excess (), although the effects on bone mineral content seem to overcome those on bone area ().”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    Hyperfunctioning pituitary diseases are caused by pituitary adenomas.

    “Hyperfunctioning pituitary diseases are caused by pituitary adenomas.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    In a proposed model, a prevalent role of TSH in driving fracture risk may be hypothesized in the presence of normal thyroid hormone levels, and a less relevant role for TSH may be suggested when thyroid hormones rise above the normal levels.

    “In this model a prevalent role of TSH in driving fracture risk may be hypothesized in the presence of normal thyroid hormone levels.A less relevant role for TSH may be suggested when thyroid hormones rise above the normal levels.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    At the femoral neck, volumetric BMD, bone volume fraction, and Tb.N are also strikingly increased in FSH haploinsufficient mice.

    “At the femoral neck, volumetric BMD, bone volume fraction, and Tb.N were also strikingly increased.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [198] Sun, 2006, FSH directly regulates bone mass, Cell source
  • May combine two claims.

    Study design and conductcitation

    DXA does not distinguish between cortical and trabecular bone, and densitometric results are greatly influenced by the variable distribution of these two compartments in the different skeletal sites.

    “DXA does not distinguish between cortical and trabecular bone, and densitometric results are greatly influenced by the variable distribution of these two compartments in the different skeletal sites ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    When PRL values are very high, bone resorption is further stimulated, whereas bone formation is suppressed with consequent impairment of trabecular bone microstructure.

    “When PRL values are very high, bone resorption is further stimulated, whereas bone formation is suppressed with consequent impairment of trabecular bone microstructure.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    The hypercalciuria observed in acromegaly patients is classically linked to increased intestinal calcium absorption driven by calcitriol, as well as to the increased bone turnover induced by GH excess.

    “The hypercalciuria observed in acromegaly patients is classically linked to increased intestinal calcium absorption driven by calcitriol, as well as to the increased bone turnover induced by GH excess ().”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning

    These effects were independent of thyroid hormones because the women did not have a thyroid gland, and replacement therapy with L-thyroxine was stable during the study period.

    “Of note, these effects were independent of thyroid hormones because the women did not have a thyroid gland, and replacement therapy with L-thy- roxine was stable during the study period.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [257] Mazziotti, 2005, Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma, J Bone Miner Res source
  • May combine two claims.

    Interpretationreasoning

    PRL exerts direct actions on bone remodeling with effects dependent on circulating hormone values and influenced by effects of sex hormones and calcium supply.

    “In summary, PRL exerts direct actions on bone remodeling with effects that were shown to be dependent on the circulating hormone values and influenced by the effects of sex hormones and calcium supply.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Pathologically high GH and IGF-I levels exert a deleterious effect on trabecular microarchitecture, whereas cortical bone density tends to be increased as an effect of GH on periostal ossification.

    “In fact, pathologically high GH and IGF-I levels exert a deleterious effect on trabecular microarchitecture, whereas cortical bone density tends to be increased as an effect of GH on periostal ossification ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Patients with active acromegaly frequently have phosphate and calcium abnormalities, such as mild hyperphosphatemia, a tendency toward increased plasma calcium levels, and hypercalciuria independently of PTH.

    “Patients with active acromegaly frequently have phosphate and calcium abnormalities, such as mild hyperphosphatemia, a tendency toward increased plasma calcium levels, and hypercalciuria independently of PTH (, ).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    When PRL values increase in the range of mild hyperprolactinemia, bone remodeling is further stimulated, with bone resorption increasing more than bone formation.

    “When PRL values increase in the range of mild hyperprolactinemia, bone remodeling is further stimulated, with bone resorption increasing more than bone formation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Vertebral fractures developed more frequently at the thoracic spine and were most commonly anterior wedge fractures.

    “Interestingly, VFs developed more frequently at the thoracic spine and they were most commonly anterior wedge fractures (), possibly contributing to kyphosis of patients with acromegaly, a feature clearly present in the first patients reported by Pierre-Marie ().”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Bonadonna et al. identified for the first time vertebral fractures in approximately 50% of postmenopausal women with acromegaly, although densitometric osteoporosis was present in less than 30% of the entire population.

    “Bonadonna et al. () identified for the first time VFs in ~% of postmenopausal women with acromegaly, although densitometric osteoporosis was present in ,% of the entire population.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Incident vertebral fractures developed in 42% of patients with acromegaly during a 3-year follow-up, in close relationship with baseline disease status and duration of active disease.

    “Incident VFs developed in % of patients with acromegaly during a -year follow-up, in close relationship with baseline disease status (i.e., higher incidence in patients with active acromegaly) and duration of active disease.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In another study performed in patients with long-standing controlled acromegaly, deletion of exon 3 of GHR was associated with higher prevalence of colonic polyps, dolichocolon, and osteoarthritis, without any significant impact of GHR polymorphism on BMD and vertebral and nonvertebral fractures.

    “In another study performed in patients with long-standing controlled acromegaly, deletion of exon- of GHR was associated with higher prevalence of colonic polyps, dolichocolon, and osteoarthritis, without any significant impact of GHR polymorphism on BMD and vertebral and nonvertebral fractures ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Elevated plasma phosphate concentrations are related both to increased calcitriol-stimulated dietary phosphate absorption and to a direct antiphosphaturic action of IGF-I in the proximal renal tubule.

    “The elevated plasma phosphate concentrations are related both to increased calcitriol-stimulated dietary phosphate absorption and to a direct antiphosphaturic action of IGF-I in the proximal renal tubule, whereas it is uncertain whether hyperphosphatemia may correlate with high bone turnover (, ).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationreasoning

    The increase of OPG may realize a feed-forward loop inhibiting osteoclastogenesis.

    “Interestingly, the increase of OPG may realize a feed-forward loop inhibiting osteoclastogenesis.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The overall median prevalence of vertebral fractures in acromegaly was calculated to be approximately 40%, with a fracture risk threefold to eightfold higher than in control subjects.

    “Other cross-sectional studies confirmed these findings (, , , ), and the overall median prevalence of VFs was calculated to be ~%, with a fracture risk that was threefold to eightfold higher in acromegaly patients as compared with control subjects ().”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    There is evidence that TSH may directly inhibit osteoclastogenesis and bone resorption, with concomitant increase in bone formation when hormone exposure is intermittent.

    “In summary, there is evidence that TSH may directly inhibit osteoclastogenesis and bone resorption, with concomitant increase in bone formation when hormone exposure is intermittent.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductreasoning

    The cross-sectional studies were not able to define the causal relationship between GH hypersecretion and vertebral fractures and did not provide reliable information on the clinical predictors of fractures in acromegaly.

    “The abovementioned cross-sectional studies were not able to define the causal relationship between GH hypersecretion and VFs and did not provide reliable information on the clinical predictors of fractures in this clinical setting.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The clinical relevance of FSH's effect on bone in humans is still largely uncertain, because patients with central hypogonadism are at high risk of bone loss notwithstanding low FSH values.

    “The clinical relevance of this effect in humans is still largely uncertain, because patients with central hypogonadism are at high risk of bone loss notwithstanding low FSH values”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    Most patients with acromegaly show normal or even increased BMD at various skeletal sites, and osteopenia and osteoporosis are not common features in acromegaly.

    “Most patients with acromegaly show normal or even increased BMD at various skeletal sites, and osteopenia and osteoporosis are not common features in acromegaly.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisereasoning

    There are no clinical studies specifically evaluating the direct effects of PRL at different concentrations, because in most cases the relative contributions of PRL excess and sex steroid deficiency are difficult to discriminate.

    “There are no clinical studies specifically evaluating the direct effects of PRL at different concentrations, because in most cases the relative contributions of PRL excess and sex steroid deficiency are difficult to be discriminated.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Polymorphism of GHR characterized by deletion of exon 3 with consequent higher sensitivity to GH was associated with a higher prevalence of vertebral fractures in patients with acromegaly, with stronger association in females as compared with males.

    “Polymorphism of GHR, characterized by deletion of exon- with consequent higher sensitivity to GH, was associated with a higher prevalence of VFs in patients with acromegaly (), with stronger association in females as compared with males ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In patients with TSH-oma with persistent hyperthyroidism after neurosurgery, first-generation SRLs can normalize TSH and thyroid hormone levels in more than 90% of patients and reduce tumor size in more than 40% of patients.

    “Patients with TSH-oma with persistent hyperthyroidism after neurosurgery can be treated with firstgeneration SRLs that can normalize TSH and thyroid hormone levels in .% of patients and reduce tumor size in .% of patients ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Acromegaly was shown to affect cortical bone in terms of increased porosity and impaired cortical strength.

    “Besides the abnormalities in trabecular microstructure, acromegaly was shown to also affect cortical bone in terms of increased porosity (, , ) and impaired cortical strength ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In untreated GHD, vertebral fractures are associated with BMD, with highest fracture risk in patients with T score below -2.0 SD.

    “In patients with untreated GHD, VFs were associated with BMD, because the highest risk to develop fractures was found in patients with a T score below 2. SD ().”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    In clinical trials, octreotide LAR and lanreotide autogel normalize GH and IGF-I in half to two-thirds of patients, whereas success rate is lower in surveys involving nonselected cohorts.

    “In clinical trials, octreotide LAR and lanreotide autogel have been reported to normalize GH and IGF-I in half to two-thirds of patients (), whereas success rate was shown to be lower in surveys involving nonselected cohorts of patients ().”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    When performed by experienced neurosurgeons, remission of pituitary hyperfunction can be achieved in 80% to 90% of patients with microadenomas and 40% to 70% of those with macroadenomas, with a 10% to 20% recurrence rate over several years.

    “remission of pituitary hyperfunction can be achieved in % to % of patients with microadenomas and % to % of those with macroadenomas, with a % to % of recurrence rate over several years (, ).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premiseown data

    The prevalence of vertebral fractures in postmenopausal women with PRL-oma was higher than in control women of comparable age, in close relationship with duration of hyperprolactinemia (OR 1.16; 95% CI 1.04 to 1.30) but not with age of onset of hyperprolactinemia (OR 0.72; 95% CI 0.4 to 3.6).

    “Of note, the prevalence of VFs in postmenopausal women was higher as compared with control women of comparable age, in close relationship with the duration of hyperprolactinemia (OR, .; % CI, . to .) but not with the age of onset of hyperprolactinemia (OR, .; % CI, . to .).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Dopamine agonists are the first-line therapy of PRL-oma because they may normalize PRL values, decrease tumor mass, and improve clinical symptoms in most patients.

    “Dopamine agonists are the first-line therapy of PRL-oma because they may normalize PRL values, decrease tumor mass, and improve clinical symptoms in most patients (, ).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationreasoning

    PRL-oma causes high bone turnover osteoporosis, with low BMD occurring in most patients, especially when the disease develops in the first decades of life before the achievement of peak bone mass.

    “In summary, PRL-oma causes high bone turnover osteoporosis, with low BMD occurring in most patients, especially when the disease develops in the first decades of life before the achievement of peak bone mass.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The higher frequency of incident vertebral fractures with pegvisomant compared with SRLs may reflect different severity of acromegaly in patients treated with the two drugs.

    “In fact, such a finding may reflect different severity of acromegaly in patients treated with the two drugs.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    The annual fracture rate was 1.4% before and 1.2% after diagnosis among patients with PRL-oma, and 0.9% and 1.0%, respectively, among controls.

    “The annual fracture rate was .% before and .% after diagnosis among the patients with PRL-oma, and .% and .%, respectively, among their controls ().”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In a study of 78 women with PRL-oma, radiological vertebral fractures were found in 25 women (32.6%), with prevalence higher in postmenopausal women (22 of 40) than in premenopausal women (3 of 38).

    “The first study was carried out in  women ( were premenopausal and  were in the postmenopausal period) who were evaluated for VFs using quantitative morphometry ().Radiological VFs were found in  out of these women (.%), with the prevalence being higher in postmenopausal women ( of ) as compared with premenopausal women ( of ).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given

    In Cushing's original series of 12 patients published in 1932, radiographic osteoporosis was reported in 1 patient, 6 patients were reported to have kyphosis, and 2 were reported to have spontaneous fractures.

    “In Cushing's original series of  patients published in , radiographic osteoporosis was reported in  patient,  patients were reported to have kyphosis, and  were reported to have spontaneous fractures.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Hong et al. found a 6% lower trabecular bone score in males and females with acromegaly as compared with control subjects, without any significant difference in BMD.

    “Hong et al. () found a % lower TBS in males and females with acromegaly as compared with control subjects, without any significant difference in BMD.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Cushing's disease, TBS is deteriorated more than BMD, but neither parameter is associated with fractures.

    “TBS was shown to be deteriorated more than BMD, but both the parameters were not associated with fractures ().”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Monitoring of mifepristone treatment can be difficult because ACTH and cortisol levels increase rather than decrease, and overdosing causing adrenal insufficiency can occur.

    “Monitoring of mifepristone treatment can be difficult because ACTH and cortisol levels increase rather than decrease, and overdosing causing adrenal insufficiency can occur ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationreasoning

    Bone turnover is invariably increased in patients with active acromegaly, whereas BMD as measured by DXA is generally slightly decreased or even normal.

    “Bone turnover is invariably increased in patients with active acromegaly, whereas BMD as measured by DXA is generally slightly decreased or even normal.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In acromegaly, lumbar BMD does not differ between patients with and without fractures, but meta-analysis heterogeneity was too high to conclude.

    “These studies did not show any difference in BMD between the two groups, although the heterogeneity was too high to achieve conclusions in this regard ().”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Cabergoline is more effective in normalizing PRL values, with fewer side effects, compared with bromocriptine.

    “Carbergoline was shown to be more effective in normalizing PRL values, with fewer side effects, as compared with bromocriptine ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S1 (asserted).

    Interpretationreasoning

    Bone loss in patients with hyperprolactinemia may be synergistically determined by increased PRL levels per se and by concomitant sex hormone deprivation.

    “Therefore, it is possible to hypothesize that bone loss in patients with hypeprolactinemia may be synergistically determined by increased PRL levels per se and by the concomitant sex hormone deprivation.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    Patients with PRL-oma are predisposed to develop osteopenia, osteoporosis, and fragility fractures as an effect of hypogonadism induced by PRL excess, as well as direct actions of PRL on bone cells and calcium metabolism.

    “Patients with PRL-oma are predisposed to develop osteopenia, osteoporosis, and fragility fractures as an effect of hypogonadism induced by PRL excess, as well as an effect of direct actions of PRL on bone cells and calcium metabolism ().”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In acromegaly, incident vertebral fractures occur more frequently during treatment with pegvisomant compared with SRLs.

    “In a prospective study, incident VFs were reported to occur more frequently during treatment with pegvisomant as compared with SRLs ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites ()

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Currently available adrenal steroidogenesis inhibitors have variable efficacy and significant side effects, but they are not approved by the US Food and Drug Administration for Cushing's disease.

    “Currently available adrenal steroidogenesis inhibitors, including ketoconazole, metyrapone, etomidate, and mitotane, have variable efficacy and significant side effects, but they are not approved by the US Food and Drug Administration for CD ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Skeletal fragility is a frequent complication of endogenous hypercortisolism, and fragility fractures may be the presenting clinical feature of disease.

    “Indeed, skeletal fragility is a frequent complication of endogenous hypercortisolism, and fragility fractures may be the presenting clinical feature of disease (, ).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    There is consistent evidence that GH excess causes deterioration of bone microstructure leading to high risk of vertebral fractures in close relationship with duration of active acromegaly.

    “In summary, there is consistent evidence that GH excess causes deterioration of bone microstructure leading to high risk of VFs in close relationship with duration of active acromegaly.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The pathogenesis of PRL-oma-induced bone loss is multifactorial, because both direct and indirect (hypogonadism) skeletal effects of hyperprolactinemia may be involved.

    “The pathogenesis of PRL-oma-induced bone loss is multifactorial, because both direct and indirect (hypogonadism) skeletal effects of hyperprolactinemia may be involved.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In untreated GHD, all patients with osteoporosis and all but one with osteopenia had vertebral fractures.

    “all untreated patients with osteoporosis (T score # 2. SD) and all but one patient with osteopenia (T score between 2. and 2. SD) had VFs.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Bone loss in Cushing disease was more pronounced at the lumbar spine and femoral neck, consistent with the view that trabecular bone is a principal target for the detrimental actions of glucocorticoid excess in the skeleton.

    “The bone loss was more pronounced at the lumbar spine and femoral neck, consistent with the view that trabecular bone is a principal target for the detrimental actions of glucocorticoid excess in the skeleton (, , -).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Neurosurgery is the first-line therapy for Cushing's disease, acromegaly, and TSH-oma.

    “Neurosurgery is the first-line therapy of CD (), acromegaly (, ), and TSH-oma ().”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • The quote only partly states this claim.

    Interpretationreasoning

    In such patients, evaluation of bone microstructure may provide reliable information on the risk of fractures.

    “the evaluation of bone microstructure may provide some reliable information on the risk of fractures”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Pegvisomant is a pegylated recombinant GH analog designed to interfere with dimerization of GHR and thus blocks production of IGF-I without any direct effect on pituitary tumor.

    “Pegvisomant is a pegylated recombinant GH analog designed to interfere with dimerization of GHR and thus blocks production of IGF-I () without any direct effect on pituitary tumor.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    In acromegaly, vertebral fractures occur even in patients with normal BMD, especially when acromegaly is active.

    “VFs occurred even in patients with normal BMD, especially when acromegaly was active ()”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    In an uncontrolled study of 48 naive patients with active acromegaly, trabecular bone score was found to be partially degraded, whereas BMD z scores in most compartments did not differ from 0.

    “In another uncontrolled study performed in  naive patients with active acromegaly, TBS was found to be partially degraded according to the definition by the manufacturer, whereas BMD z scores in most compartments did not differ from  ().”
    Quote in the paperSubstantial claim
  • May combine two claims. The quote only partly states this claim.

    Premisecitation

    The prevalence of vertebral fractures was not significantly different between eugonadal and hypogonadal patients with PRL-oma, and no significant difference in serum testosterone values was found between males with or without fractures.

    “Interestingly, the prevalence of VFs was not significantly different between eugonadal and”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In a second cross-sectional study, radiological vertebral fractures were found in 37.5% of male patients with PRL-oma, with prevalence about fivefold higher as compared with control subjects.

    “In the second crosssectional study, radiological VFs were found in .% of male patients with PRL-oma, with the prevalence being about fivefold higher as compared with control subjects ().”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    In patients with pituitary diseases, experience with fracture risk assessment algorithms is limited, with inconclusive results concerning their reliability in predicting fractures.

    “In patients with pituitary diseases, the experience with these algorithms is limited (, ), with inconclusive results concerning the reliability in predicting fractures in this clinical setting.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Biochemical control of acromegaly is accompanied by variable changes in BMD and persistently abnormal bone structure.

    “This biochemical effect was accompanied by variable changes in BMD (, , , , , , , ) and with persistently abnormal bone structure (, ).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Mifepristone is a glucocorticoid receptor antagonist that improves glucose tolerance, body weight, and quality of life in Cushing's disease.

    “Mifepristone is a glucocorticoid receptor antagonist that improves glucose tolerance, body weight, and quality of life in CD ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Eighty percent of male patients with PRL-oma were found to have densitometric diagnosis of either osteopenia or osteoporosis at the lumbar spine, whereas only 30% showed a low BMD at the femoral neck.

    “Eighty percent of male patients with PRL-oma were found to have densitometric diagnosis of either osteopenia or osteoporosis at the lumbar spine, whereas only a minority of them (%) showed a low BMD at the femoral neck, suggesting that trabecular bone was damaged earlier than cortical bone (, , ).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In some studies, BMD was correlated with PRL levels, biochemical markers of bone turnover, and duration of disease, but not with serum testosterone values in males or estradiol values and coexistent amenorrhea in women.

    “In some studies, BMD was correlated with PRL levels, biochemical markers of bone turnover, and duration of disease, but not with serum testosterone values in males () or estradiol values and coexistent amenorrhea in women ().”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The increase in BMD after cure of CD is larger and occurs earlier at the lumbar spine compared with the total hip.

    “The increase in BMD was larger and occurred earlier at the lumbar spine as compared with the total hip (, ).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites (, )

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation

    Changes in BMD after cure of CD are time-dependent and skeletal site specific.

    “Changes in BMD after the cure of CD are time-dependent and skeletal site specific.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In a retrospective analysis, no incident clinical fractures were registered during a period of 4 years after cure of hypercortisolism, although the number of patients with long-term follow-up was too low to draw definitive conclusions.

    “In a retrospective analysis, no incident clinical fractures were registered during a period of  years after the cure of hypercortisolism, although the number of patients with long-term follow-up was too low to draw definitive conclusions ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites ()

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Vestergaard et al. reported a significant decrease in risk of clinical fractures early after diagnosis of CD, although it was not specified whether this outcome was related to correction of hypercortisolism or to other treatments.

    “In fact, Vestergaard et al. () reported a significant decrease in risk of clinical fractures early after diagnosis of CD (Table ), although it was not specified whether this outcome was related to correction of hypercortisolism or to other treatments (e.g., sex steroids or vitamin D) potentially impacting fracture risk in this clinical setting (-).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites ()

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    A high prevalence of vertebral fractures is reported in patients with long-standing cured CD, although the cross-sectional design did not allow definition of timing of fracture development and progression in relationship to outcome of hypercortisolism.

    “Alternatively, a high prevalence of VFs was reported in patients with long-standing cured CD (Table ), although the cross-sectional design did not allow definition of the timing of fracture development and progression in relationship to the outcome of hypercortisolism ().”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites ()

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation

    Fractures are a hallmark of skeletal fragility in CD, as observed in other pituitary diseases.

    “Of note, patients with previous fractures were predisposed to develop new fractures after treatment of CD (), confirming that fractures are a hallmark of skeletal fragility in CD such as observed in other pituitary diseases (, ).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites (, )

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Densitometric outcomes after treatment of hypercortisolism are variable: some patients recover normal BMD and others show persistently abnormal BMD for several years after cure of CD.

    “These changes in bone turnover are expected to be associated with an increase in BMD, although the densitometric outcomes after treatment of hypercortisolism were shown to be variable, with some patients recovering normal BMD (, ) and others showing persistently abnormal BMD for several years after the cure of CD (, -).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites (, )

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites (, -)

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    HR-pQCT is apparently the gold standard for assessing bone quality and microstructure.

    “In fact, although HR-pQCT is apparently the gold standard in the arena, its costs make its availability for routine evaluation unrealistic.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisenone given

    The role of bone-active drugs in the treatment of bone complications in pituitary diseases is almost unexplored.

    “Another so far almost unexplored territory is the role of bone-active drugs in the treatment of bone complications in pituitary diseases.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    rhGH is antiphosphaturic and increases intestinal absorption of phosphate, leading to an increase in serum phosphate levels.

    “rhGH is antiphosphaturic and increases the intestinal absorption of phosphate, leading to an increase in serum phosphate levels (-).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites (-)

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    There is a close association between fragility fractures and severity of hypercortisolism and duration of disease.

    “The close association between fragility fractures and severity of hypercortisolism () and duration of disease () suggests that an early treatment of CD may have a favorable impact on fracture risk ().”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites ()

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites ()

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Premisenone given

    Costs of HR-pQCT make its availability for routine evaluation unrealistic.

    “In fact, although HR-pQCT is apparently the gold standard in the arena, its costs make its availability for routine evaluation unrealistic.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    The effect of rhGH on bone remodeling is biphasic: rhGH causes a maximal effect on bone resorption after 3 months and on bone formation after 6 months.

    “The effect of rhGH on bone remodeling is biphasic; that is, rhGH causes a maximal effect on bone resorption after  months and on bone formation after  months.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites (, , -)

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation

    The increase in serum and urinary calcium caused by rhGH is due to calcium mobilization from the skeleton, increased intestinal calcium absorption, and increased renal reabsorption of calcium due to increased sensitivity to PTH.

    “rhGH causes an increase in serum and urinary calcium after  to  months, an effect caused by calcium mobilization from the skeleton, an increase in intestinal calcium absorption, and in the renal reabsorption of calcium due to increased sensitivity to PTH (-).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    L-T4 doses in central hypothyroidism average 1.6 mg/kg/d, based on evidence that this dose is associated with improvement in several clinical endpoints of central hypothyroidism.

    “L-T doses in central hypothyroidism average . mg/kg/d, based on the evidence that this hormone dose was associated with an improvement in several clinical endpoints of central hypothyroidism (-).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites (-)

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    In patients with PRL-oma, BMD values only partially improve during treatment and remain lower than in normal control subjects.

    “BMD values, however, only partially improved during treatment, remaining still lower as compared with normal control subjects (, -, , -).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites (, -, , -)

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Correction of hypercortisolism is accompanied by a marked increase in osteocalcin levels and moderate increase or even decrease in NTX levels.

    “Correction of hypercortisolism was accompanied by a marked increase in osteocalcin levels and moderate increase or even decrease in NTX levels (, ).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites (, )

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

86 of 86
  • The paper relies on this without support.

    Skeletal fragility associated with high risk of fractures is a common complication of hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia.

    “Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia.”
  • The paper relies on this without support.

    The control groups in the cited studies are appropriate comparators for patients with pituitary disease.

    “as compared with control subjects”
  • The paper relies on this without support.

    The fracture definitions used in the cited studies accurately identify fragility fractures.

    “radiological VFs were found”
  • The paper relies on this without support.

    Bisphosphonates inhibit bone resorption.

    “Bisphosphonates inhibit bone resorption and are the most commonly prescribed drugs for the treatment of osteoporosis.”
  • The paper relies on this without support.

    Bisphosphonates may potentially delay the recovery of bone remodeling after resolution of endogenous hypercortisolism.

    “In fact, it should be considered that bisphosphonates may potentially delay the recovery of bone remodeling after resolution of endogenous hypercortisolism.”
  • The paper relies on this without support.

    Pituitary diseases are burdened by relevant osteometabolic derangements.

    “Pituitary diseases are burdened by relevant osteometabolic derangements.”
  • The paper relies on this without support.

    For mainly economic reasons, substitution with rhGH has become progressively less popular in our health systems and among endocrinologists.

    “For mainly economic reasons the substitution with rhGH has become progressively less popular in our health systems and among endocrinologists.”
7 of 7

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Four GHD drug studies are called alendronate studies, but one used pamidronate

    Minor

    Of the four GHD studies discussed immediately afterward and listed in Table 5, the Valk study used pamidronate rather than alendronate.

  • The same PRL model is described as having both unchanged and decreased BMD

    Minor

    The description of the experimental model first says BMD was not altered, then refers to a decrease in BMD in that model.

2 of 2

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mazziotti, G., Frara, S., & Giustina, A.
Affiliations
  • Azienda Ospedaliera Carlo Poma (IT)
  • Vita-Salute San Raffaele University (IT)
Corresponding author
Giustina, Andrea
Venue
Endocrine Reviews
Published
2018-04-19
Volume
39
Issue
4
Pages
440-488
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2802757031
Cited by
181
References
648
Citations by year
2026: 13 · 2025: 20 · 2024: 31 · 2023: 20 · 2022: 21 · 2021: 26 · 2020: 23 · 2019: 18 · 2018: 6
FWCI
17.73
Type
journal article
Language
en
Open access
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Funders
  • Pfizer
  • Astellas Pharma
  • Ipsen
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
pituitary disorders, bone, bone remodeling, bone metabolism, hypopituitarism, Cushing's disease, acromegaly, hyperprolactinemia, secondary osteoporosis, fracture risk, bone mineral density, bone quality
MeSH terms
Animals, Humans, Osteoporosis, Pituitary Diseases, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-28.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-28.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review